Benzoyl Peroxide
This Medication Should Always be Used Exactly as Described in the Patient Leaflet or as Advised by a Doctor or Pharmacist.
Benzacne is a Medication in the Form of a Gel with Anti-Acne Action, Intended for Local Application to the Skin.
The Medication Contains the Active Substance Benzoyl Peroxide. Benzoyl Peroxide, After Application to the Skin, Easily Penetrates the Stratum Corneum and Inhibits the Growth of Anaerobic Bacteria Propionibacterium Acnes, which are one of the Causes of Common Acne.
It also Acts as a Keratolytic Agent on the Skin, Reducing the Number of Comedones.
Benzacne is Indicated for the Treatment of Various Forms of Common Acne (Acne Vulgaris).
Before Starting to Use Benzacne, Discuss it with a Doctor or Pharmacist.
Tell Your Doctor or Pharmacist about all Medications You are Currently Taking or have Recently Taken, as well as any Medications You Plan to Take.
Concurrent Use of Benzacne with:
In Case of Need for Concurrent Use of any other Medications, Consult a Doctor to Determine Possible Changes in the Use of Benzacne.
Do not Use in Children Under 12 Years of Age.
If You are Pregnant or Breastfeeding, Think You may be Pregnant or are Planning to have a Child, Consult a Doctor or Pharmacist Before Using this Medication.
Do not Apply the Medication to the Breast Area During Breastfeeding.
Benzacne Does not Affect the Ability to Drive and Operate Machines.
This Medication Should Always be Used Exactly as Described in the Patient Leaflet or as Advised by a Doctor or Pharmacist. In Case of Doubt, Consult a Doctor or Pharmacist.
Recommended Dose
Adults and Children Over 12 Years of Age
Apply Once or Twice a Day.
Usually, Within the First 2 to 3 Weeks of Treatment, the Medication with a Benzoyl Peroxide Content of 50 mg/g is Used, and if Necessary, the Treatment is Continued with the Medication with a Benzoyl Peroxide Content of 100 mg/g.
Method of Administration
The Medication is Intended for Local Application to the Skin.
After Washing and Drying the Skin, Apply a Small Amount of the Medication, Sufficient to Cover the Affected Areas, and Gently Rub it in.
After Applying the Medication, Wash Your Hands.
If You Feel that the Action of the Medication is too Strong or too Weak, Consult a Doctor.
A Symptom of Overuse of Benzacne is Redness or Swelling of the Skin. If they Occur, Stop Using the Medication Immediately and Consult a Doctor.
Cold Compresses can be Applied to the Irritated Areas.
Do not Use a Double Dose to Make up for a Missed Dose.
Like all Medications, Benzacne can Cause Side Effects, although not Everybody gets them.
During Treatment with Benzacne, the Following may Occur:
If the Following Symptoms Occur, Stop Using the Medication and Consult a Doctor:
If You Experience any Side Effects, including those not Listed in this Leaflet, Tell Your Doctor or Pharmacist, or Nurse. Side Effects can be Reported Directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181 C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side Effects can also be Reported to the Marketing Authorization Holder.
By Reporting Side Effects, You can Help Provide more Information on the Safety of this Medication.
Store the Medication at a Temperature Below 25°C. Do not Freeze.
Store the Medication in a Place Out of Sight and Reach of Children.
Do not Use this Medication After the Expiration Date Stated on the Tube and Carton after the EXP. The Expiration Date Refers to the Last Day of the Specified Month.
Medications should not be Disposed of in Sewers or Household Waste Containers. Ask Your Pharmacist how to Dispose of Medications that are no Longer Needed. This will Help Protect the Environment.
Benzacne is a White, Odorless Gel.
50 mg/g: The Medication is Available in a Tube Containing 30 g of Gel, Placed in a Cardboard Box.
100 mg/g: The Medication is Available in a Tube Containing 20 g of Gel, Placed in a Cardboard Box.
Orifarm Healthcare A/S
Energivej 15
5260 Odense S
Denmark
To Obtain more Detailed Information about this Medication, Contact the Local Representative of the Marketing Authorization Holder:
Orifarm Healthcare Sp. z o.o.
ul. Przyokopowa 31
01-208 Warsaw
Poland
info-PL@orifarm.com
50 mg/g:
Orifarm Manufacturing Poland Sp. z o.o.
ul. Księstwa Łowickiego 12
99-420 Łyszkowice
Poland
100 mg/g:
Medinfar Manufacturing, S.A.
Parque Industrial Armando Martins Tavares,
Rua Outeiro da Armada, No 5,
Condeixa-a-Nova 3150-194
Portugal
Date of Last Update of the Leaflet:08/2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.